Ocular Therapeutix™ to Participate in March Investor Conferences Feb 24, 2026 07:00AM
TD Cowen on Ocular Therapeutix (OCUL): 'Great Data Could Lead To 45% Upside Per Investor Survey' Dec 16, 2025 08:38AM
Ocular Therapeutix (OCUL) PT Raised to $20 at TD Cowen Oct 30, 2025 09:38AM
Ocular Therapeutix prices $475 million stock offering at $12.53 per share Sep 30, 2025 07:08AM
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock Sep 30, 2025 07:08AM


Aug 5, 2025 12:45PM TD Cowen on Ocular Therapeutix (OCUL): 'SOL-1 Data In Q1:2026 Should Be Positive And Clinically Relevant'
Feb 25, 2025 07:00AM Ocular Therapeutix™ to Present at Two Investor Conferences in March
Jun 20, 2024 06:48AM TD Cowen Upgrades Ocular Therapeutix (OCUL) to Buy
Jun 14, 2024 07:47AM TD Cowen Reiterates Hold Rating on Ocular Therapeutix (OCUL)
May 8, 2024 10:55AM Ocular Therapeutix (OCUL) PT Lowered to $7 at TD Cowen
Feb 28, 2023 08:00AM Ocular Therapeutix™ to Present at Cowen’s 43rd Annual Healthcare Conference
Mar 4, 2022 08:00AM Ocular Therapeutix™ to Present at the Cowen 42nd Annual Healthcare Conference
Feb 24, 2021 08:00AM Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
Mar 3, 2020 07:36AM Ocular Therapeutix (OCUL) Announces Preliminary Fourth Quarter 2019 Net Product Revenue and Provides Update on Interim Data from the OTX-TKI Phase 1 Clinical Trial
Mar 3, 2020 07:30AM Ocular Therapeutix™ Announces Preliminary Fourth Quarter 2019 Net Product Revenue and Provides Update on Interim Data from the OTX-TKI Phase 1 Clinical Trial at the Cowen 40th Annual Health Care Con
Feb 25, 2020 08:00AM Ocular Therapeutix™ to Present at the Cowen and Company 40th Annual Health Care Conference
May 21, 2019 06:34AM UPDATE: Cowen Downgrades Ocular Therapeutix (OCUL) to Market Perform
Mar 5, 2019 08:00AM Ocular Therapeutix™ to Present at the Cowen and Company 39th Annual Health Care Conference
Jul 11, 2018 07:02AM Ocular Therapeutix (OCUL) PT Lowered to $13 at Cowen
Feb 28, 2018 08:00AM Ocular Therapeutix™ to Present at the Cowen and Company 38th Annual Health Care Conference
Jun 23, 2017 09:21AM Pre-Open Movers 06/23: (AVEO) (SNCR) (CARA) Higher; (WKHS) (BBBY) (BBRY) Lower (more...)
Mar 13, 2017 07:38AM Ocular Therapeutix (OCUL): Dextenza On Track To Meet Low Hurdles - Cowen
Feb 22, 2017 09:30AM Pre-Open Stock Movers 02/22: (SRRA) (GRMN) (TOL) Higher; (ARGS) (SREV) (TXRH) Lower (more...)
Feb 9, 2017 04:05PM Ocular TherapeutixTM to Present at Three Upcoming Investor Conferences
Aug 11, 2016 10:27AM Notable Analyst Rating Changes 8/11: (COG) (TMH) (AEO) Upgraded; (QHC) (CBOE) (BMY) Downgraded
Jun 6, 2016 09:38AM Pre-Open Stock Movers 06/06: (VBLT) (YGE) (ONTY) Higher; (DNAI) (ADMP) (MRTX) Lower (more...)
Feb 18, 2016 08:00AM Ocular TherapeutixTM to Present at Two Upcoming Investor Conferences
Jul 28, 2015 04:03PM Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
Jun 5, 2015 06:55AM Ocular Therapeutix (OCUL) Prices 4M Common Share Offering at $22/Share
Jun 4, 2015 09:40PM Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock
Jun 2, 2015 04:07PM Ocular Therapeutix (OCUL) Announces 4M Common Offering; Holders to Sell 800k Shares
Jun 2, 2015 04:05PM Ocular Therapeutix, Inc. Announces Proposed Public Offering of Common Stock
Aug 19, 2014 09:02AM Cowen Starts Ocular Therapeutix (OCUL) at Outperform
Jul 25, 2014 01:12PM Ocular Therapeutix (OCUL) IPO Open, Trades Flat